The International Society of Pharmacometrics (ISoP) is seeking the membership’s input to identify qualified candidates willing to serve as members of the ISoP Board of Directors, to fill open positions on the Board effective January 1, 2021. http://go-isop.org/2021-isop-board-of-directors-nominations/ The ISoP Board is made up of dedicated, motivated ISoP members whose goal is to lead the…
The International Society of Pharmacometrics seeks to recognize innovative science and outstanding leadership in the field of pharmacometrics and related scientific areas, with the following award categories. All Awards Lewis B. Sheiner Lecturer Award ISoP Innovation Award ISoP Leadership Award ISoP Outstanding Research Manuscript Award ISoP Emerging Scientist Award ISoP Unsung Hero Award Please click…
We are delighted to invite you to the first International Society of Pharmacometrics (ISoP) Regional Quantitative Systems Pharmacology (QSP) Day 2019, co-hosted by the ISoP QSP Special Interest Group (ISoP QSP SIG) and Bristol-Myers Squibb (BMS). The event is intended to highlight some of the recent achievements in QSP, illustrate application areas, and promote networking,…
Please join us on Wednesday, April 17, 2019, at Social, 156 N Gaston Ave., Somerville, NJ 08876, for an evening of networking and socializing. This will be a casual event for local ISoP members and others in the pharmacometrics community to get together for networking, socializing, and planning for the groups upcoming events. This is…
Planning for ACoP10 is underway! The Tenth American Conference on
Pharmacometrics (ACoP10) will be held October 20th to 23rd, 2019, at the Rosen Shingle Creek Hotel in Orlando, Florida.
2019 is going to be a pivotal year for ISoP. We have a number of significant changes coming down the road, the result of a lot of time and planning by our Board and our teams of volunteers. ISoP is growing from the equivalent of a plucky startup into a mature scientific society: by 2023…
Quantitative clinical pharmacology is well established in most parts of the world, but the low- and middle-income countries (LMIC’s) are underrepresented. To address this need, a team of pharmacologists have started a new organization known as Pharmacometrics Africa. I asked some of them to tell us more about their vision for the future: View full…
Choosing optimal doses to be used in clinical trials for potential new therapies is difficult as data can be limited. The ability to identify relevant doses is further complicated when the difference between concentrations that are efficacious and those causing toxicity are narrow. Add to these issues the need to not overshoot or undershoot a…